Archive for June, 2012

Intermittent Hormone Therapy Fails the Test

A very important randomized study is being presented at the ASCO meeting and appears to show that intermittent hormone therapy results in a worse survival in men with metastatic prostate cancer compared to men on continuous therapy. This is consistent with another study done in Europe and it is important for many reasons, most importantly […]

Continue Reading